HL2351 CAPS Phase II Study

NCT02853084 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped difficult of recruiting

Conditions

Cryopyrin-Associated Periodic Syndromes (CAPS)

Interventions

DRUG: HL2351

Sponsor

Handok Inc.